Study: Merck Arcoxia Cox-2 shows fewer side effects than NSAID

02/8/2007 | Reuters

New research shows Merck's Arcoxia, a Cox-2 inhibitor for killing pain, has fewer side effects than the NSAID diclofenac, with which it was compared. The study said Arcoxia caused fewer stomach disorders and complications than diclofenac.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA